D. Magrath

发表

Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine

G. Schild, M. Skinner, D. Evans, 1989, Journal of virology.

Studies on the attenuation of the Sabin type 3 oral polio vaccine.

G. Schild, D. Evans, G. Dunn, 1987, Journal of virological methods.

Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.

G. Schild, D. Evans, P. Minor, 1985, Virology.

The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3.

D. Evans, G. Dunn, P. Minor, 1989, The Journal of general virology.

The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-1

F. Gibson, D. Magrath, 1969 .

Immunity of children to diphtheria, tetanus, and poliomyelitis.

J. W. Smith, D. Magrath, D. Bainton, 1979, British medical journal.

Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.

R. Linkins, P. Minor, D. Magrath, 1995, Bulletin of the World Health Organization.

Nucleotides. Part XXXIV. The hydrolysis of dialkyl esters of uridine-3′ phosphate and its relevance to the question of phosphotriester linkages in ribonucleic acids

D. Magrath, Daniel M. Brown, A. R. Todd, 1955 .

WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.

J. Furesz, G. Berencsi, D. Magrath, 1972, Bulletin of the World Health Organization.

Potency Assay of Inactivated Influenza and Poliovaccine

R. Webster, G. Schild, J. Wood, 1988 .

The occurrence and source of beta-alanine in alkaline hydrolysates of sRNA: a sensitive method for the detection and assay of 5,6-dihydrouracil residues in RNA.

D. Magrath, D. Shaw, 1967, Biochemical and biophysical research communications.

The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-I.

F. Gibson, D. Magrath, 1969, Biochimica et biophysica acta.

Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.

A. Huovilainen, P. Minor, T. Hovi, 1987, The Journal of general virology.

A W.H.O. collaborative study of in vitro and in vivo methods for the assay of yellow fever vaccines.

V. Seagroatt, D. Magrath, Valerie Seagroatt, 1983, Journal of biological standardization.

Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population.

G. Schild, D. Evans, P. Minor, 1986, The Journal of general virology.

Improved syntheses of aminoacridines. Part III.1 1:9‐dimethylproflavine

D. Magrath, A. Albert, 1945 .

Purine N-Oxides. I. Mono-oxides of Aminopurines1

D. Magrath, H. Smith, G. B. Brown, 1958 .

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).

D. Magrath, V. Grachev, E. Griffiths, 1998, Biologicals : journal of the International Association of Biological Standardization.

Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine.

G. Schild, M. Skinner, D. Evans, 1987, Biochemical Society symposium.

The growth in vitro of vaccinia virus in chick embryo chorio-allantoic memberane, minced embryo and cell suspensions

H. B. Maitland, D. Magrath, 1957, Journal of Hygiene.

511. Nucleotides. Part XII. The preparation of cyclic 2′ : 3′-phosphates of adenosine, cytidine, and uridine

D. Magrath, Daniel M. Brown, A. R. Todd, 1952 .

Aminoacyl nucleosides. VI. Isolation and preliminary characterization of threonyladenine derivatives from transfer ribonucleic acid.

P. Taylor, J. Mozejko, D. Magrath, 1969, Biochemistry.

Structure of Adenylic Acids a and b

G. Fasman, W. Cochran, M. Woolfson, 1953, Nature.

Nucleotides. Part XXVII. The structures of adenylic acids a and b

G. Fasman, D. Magrath, Daniel M. Brown, 1954 .

MONOCLONAL ANTIBODIES SPECIFIC FOR THE SABIN VACCINE STRAIN OF POLIOVIRUS 3

G. Schild, P. Minor, D. Magrath, 1982, The Lancet.

Immunoassay of poliovirus antigens by single-radial-diffusion: development and characteristics of a sensitive autoradiographic zone size enhancement (ZE) technique.

G. Schild, J. Wood, P. Minor, 1980, The Journal of general virology.

The Synthesis of 9-β-D-Ribofuranosylpurine-5'-phosphate and its Behavior Toward Aqueous Alkali1

D. Magrath, G. B. Brown, 1957 .

Nucleotides. Part XXVI. The methylation of uridylic acid b

D. Magrath, Daniel M. Brown, A. R. Todd, 1954 .

Synthesis of an Isopropylidene Derivative of an Alkali-labile Nucleoside: 2',3'-O-Isopropylidene-9-β-D- ribofuranosylpurine1

D. Magrath, A. Hampton, 1957 .

Guidelines for the acceptability, management and testing of serially propagated human diploid cells for the production of live virus vaccines for use in man.

A. J. Garrett, G. Schild, D. Magrath, 1981, Journal of biological standardization.

Synthesis of N-Phosphoryl-D- and L-Lombricine

D. Magrath, A. Ennor, I. M. Beatty, 1960, Nature.

Status of WHO concerning continuous cell lines as substrates for the production of biologicals.

D. Magrath, V. Grachev, 1989, Developments in biological standardization.

Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping.

G. Schild, P. Minor, A. John, 1982, The Journal of general virology.

The choice of a chelating agent for inactivating trace metals: II. Derivatives of oxine (8-hydroxyquinoline).

D. Magrath, A. Albert, 1947, The Biochemical journal.

WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.

G. Schild, P. Minor, D. Magrath, 1986, Bulletin of the World Health Organization.

The standardization of infectivity titrations of poliovaccines--a WHO collaborative study.

V. Seagroatt, D. Magrath, 1985, Journal of biological standardization.

Antibody state to poliovirus in first year university students, 1984.

N. Begg, D. Magrath, C. Joseph, 1987, British medical journal.

BRITISHREFERENCE PREPARATION OF HEPATITIS B SURFACE ANTIGEN

V. Seagroatt, D. Magrath, M. Ferguson, 1982, The Lancet.

Biochemistry of Lombricine: Synthesis of DL- and L-Lombricine

D. Magrath, I. M. Beatty, David I. Magrath, 1959, Nature.

Biochemistry of Lombricine: Occurrence of D-Serine in Lombricine

D. Magrath, A. Ennor, I. M. Beatty, 1959, Nature.

The Identification of Phosphorylated Metabolites of 9-β-D-Ribofuranosylpurine1

M. Gordon, D. Magrath, G. B. Brown, 1957 .

The Synthesis of D-, L- and DL-2-amino-2-carboxyethyl 2-Guanidinoethyl Hydrogen Phosphate (Lombricine) and the Identity of the Natural Compound with the D Isomer

D. Magrath, I. M. Beatty, 1960 .

Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.

G. Schild, P. Minor, D. Magrath, 1984, The Journal of general virology.

Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of life.

D. Magrath, A. E. Jones, F. Sheffield, 1989, Vaccine.

MONKEY SCOLIOSIS

L. F. Taffs, D. Magrath, N. A. Lytton, 1979, The Lancet.

Antigenic characterization of poliovirus type 3 using monoclonal antibodies.

G. Schild, P. Minor, D. Magrath, 1984, Reviews of infectious diseases.

A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating

G. Schild, M. Skinner, G. Dunn, 1992, Journal of virology.

Guide to Poliovirus Isolation and Serological Techniques for Poliomyelitis Surveillance

D. Magrath, I. Dömök, 1979 .

Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines.

G. Schild, S. Marsden, P. Reeve, 1980, Journal of biological standardization.

TWO CASES OF VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS LINKED IN TIME AND PLACE

D. Magrath, N. Gill, R. Chamberlain, 1984, The Lancet.